| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MIRATI THERAPEUTICS INC COM | 1,258,055 | 39,755,000 | 13.69% | ||
| 2 | AMICUS THERAPEUTICS INC | 3,515,611 | 34,101,000 | 11.75% | ||
| 3 | Lion Biotechnologies | 3,187,607 | 24,608,000 | 8.48% | ||
| 4 | LA JOLLA PHARMACEUTICAL CO | 784,199 | 21,173,000 | 7.29% | ||
| 5 | SAREPTA THERAPEUTICS INC | 503,007 | 19,406,000 | 6.68% | ||
| 6 | PERNIX THERAPEUTICS HLDGS IN | 5,144,916 | 15,178,000 | 5.23% | ||
| 7 | DERMIRA INC | 354,950 | 12,285,000 | 4.23% | ||
| 8 | TELIGENT INC NEW | 1,373,294 | 12,222,000 | 4.21% | ||
| 9 | VANDA PHARMACEUTICALS INC COM | 1,260,809 | 11,738,000 | 4.04% | ||
| 10 | SORRENTO THERAPEUTICS INC COM NEW | 1,146,579 | 9,987,000 | 3.44% | ||
| 11 | AGENUS INC | 2,199,137 | 9,984,000 | 3.44% | ||
| 12 | ONCOTHYREON INC COM N/C EFF 6/ | 4,119,072 | 9,144,000 | 3.15% | ||
| 13 | NEURODERM LTD | 520,022 | 8,866,000 | 3.05% | ||
| 14 | Nantkwest Inc | 599,287 | 8,828,000 | 3.04% | ||
| 15 | AEGERION PHARMACEUTICALS INC | 733,125 | 7,405,000 | 2.55% | ||
| 16 | NEUROCRINE BIOSCIE COM USD0.001 | 127,000 | 7,184,000 | 2.47% | ||
| 17 | AXOVANT SCIENCES LTD | 307,070 | 5,536,000 | 1.91% | ||
| 18 | VERACYTE INC | 741,353 | 5,338,000 | 1.84% | ||
| 19 | Egalet Corp | 432,606 | 4,767,000 | 1.64% | ||
| 20 | Innocoll | 501,722 | 4,164,000 | 1.43% | ||
| 21 | FORTRESS BIOTECH INC | 1,337,869 | 3,733,000 | 1.29% | ||
| 22 | TRILLIUM THERAPEUTICS INC | 253,697 | 3,199,000 | 1.10% | ||
| 23 | VERICEL CORP | 1,135,120 | 2,929,000 | 1.01% | ||
| 24 | TONIX PHARMACEUTICALS HLD | 340,300 | 2,610,000 | 0.90% | ||
| 25 | ACCELERATE DIAGNOSTICS INC | 112,885 | 2,426,000 | 0.84% | ||
| 26 | ALLIQUA BIOMEDICAL INC | 839,100 | 1,796,000 | 0.62% | ||
| 27 | CELLECTIS S A | 35,000 | 1,086,000 | 0.37% | ||
| 28 | SAREPTA THERAPEUTICS INC | 47,300 | 626,000 | 0.22% | Call | |
| 29 | Catalyst Biosciences | 71,500 | 224,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-081239, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
